Ghp Investment Advisors buys $2,835,595 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Ghp Investment Advisors scooped up 374 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 3, 2016. The investment management firm now holds a total of 24,696 shares of Stryker Corporation which is valued at $2,835,595.Stryker Corporation makes up approximately 0.55% of Ghp Investment Advisors’s portfolio.

Other Hedge Funds, Including , Dean Investment Associates reduced its stake in SYK by selling 545 shares or 1.44% in the most recent quarter. The Hedge Fund company now holds 37,246 shares of SYK which is valued at $4,276,586. Stryker Corporation makes up approx 0.81% of Dean Investment Associates’s portfolio.Schaper Benz Wise Investment Counsel Incwi reduced its stake in SYK by selling 1,905 shares or 1.55% in the most recent quarter. The Hedge Fund company now holds 120,792 shares of SYK which is valued at $13,869,337. Stryker Corporation makes up approx 2.44% of Schaper Benz Wise Investment Counsel Incwi’s portfolio.Peak Asset Management reduced its stake in SYK by selling 614 shares or 0.92% in the most recent quarter. The Hedge Fund company now holds 66,263 shares of SYK which is valued at $7,608,318. Stryker Corporation makes up approx 1.56% of Peak Asset Management’s portfolio.Boston Private Wealth reduced its stake in SYK by selling 8,474 shares or 3.21% in the most recent quarter. The Hedge Fund company now holds 255,700 shares of SYK which is valued at $29,359,474. Stryker Corporation makes up approx 1.16% of Boston Private Wealth’s portfolio.Jfs Wealth Advisors reduced its stake in SYK by selling 8 shares or 6.2% in the most recent quarter. The Hedge Fund company now holds 121 shares of SYK which is valued at $13,894.

Stryker Corporation closed down -0.08 points or -0.07% at $114.82 with 10,13,387 shares getting traded on Monday. Post opening the session at $114.99, the shares hit an intraday low of $114.07 and an intraday high of $115.07 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *